Goldman Sachs Group Inc (GS)

GS (NYSE:Financial Services) EQUITY
$247.35
pos +0.00
+0.00%
Today's Range: 246.10 - 248.88 | GS Avg Daily Volume: 4,130,300
Last Update: 02/24/17 - 4:01 PM EST
Volume: 0
YTD Performance: 4.90%
Open: $0.00
Previous Close: $251.19
52 Week Range: $138.20 - $252.65
Oustanding Shares: 397,649,217
Market Cap: 99,885,506,818
6-Month Chart
TheStreet Ratings Grade for GS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 6 5
Moderate Buy 2 2 2 1
Hold 9 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.26 2.22 2.29 2.40
Latest Dividend: 0.65
Latest Dividend Yield: 1.04%
Dividend Ex-Date: 02/28/17
Price Earnings Ratio: 20.03
Price Earnings Comparisons:
GS Sector Avg. S&P 500
20.03 15.40 30.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
18.31% 70.69% 52.70%
GROWTH 12 Mo 3 Yr CAGR
Revenue -2.20 -0.10 -0.03
Net Income 21.60 -0.10 -0.03
EPS 34.20 0.00 0.00
Earnings for GS:
EBITDA 0.00B
Revenue 37.71B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $5.01 $4.18 $19.60 $22.33
Number of Analysts 5 4 7 7
High Estimate $6.07 $4.41 $21.50 $25.28
Low Estimate $4.18 $3.82 $17.50 $20.00
Prior Year $2.68 $3.72 $16.29 $19.60
Growth Rate (Year over Year) 86.94% 12.50% 20.29% 13.96%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Takeaways and Observations Real Money Pro($)

 
Rising demand and falling demand are cutting the price of oil and oil-based products.

Quick Lowdown on Goldman Real Money Pro($)

Gaining market share in credit markets Believes it can increase market share in assets under management GS plans to increase the size of its lending portfolio Flexible cost base helps mitigate revenue challenges The company has been comparing 2011 to compare to 2016; sees it as tough revenue year and similar scale CEO Blankfein gave his thoughts on the market environment: U.S. stock market, dollar and oil prices have shown meaningful growth since U.S. elections. Blankfein sees a number of macro trends t

My Takeaways and Observatons Real Money Pro($)

The U.S. currency rose in today's trading session. The price of crude oil dropped by $0.73 to $53.10. Gold up $15, a good thing for my portfolio. Ag commodities continue their volatility: wheat down $0.07, corn down $0.015, soybeans down $0.105 and oats up $0.02. Lumber up $10, a meaningful move to the upside. Bonds rallied in price and declined in yields. The 10-year dropped by eight basis points to 2.41% and the long bond by 6 bps. The 2s/10s spread flattened by nearly 3 basis points to 127 bps. Lets watch this closely in the days ahead. Munis caught a bid. Junk bonds were offered small. Blackstone / GSO Strategic Credit Fund (BGB) unchanged. Banks held most of Friday's sharp gains. I was an active short seller today. Insurance was mixed. Hartford Financial (HIG) rose. I owe you all an analysis of the EPS on this one. Probably tomorrow. Brokerages a bit lower - led by Goldman Sachs (GS) (but it was a huge winner on Friday). Despite the rally in bonds, REITs were weak. I remain short iShares Dow Jones US Real Estate ETF (IYR) ( on my Best Ideas List) Fav long Oaktree Capital (OAK) , first day down in a week or more. Autos were mixed, with my pairs trade going the wrong way. Retail is a cesspool -- the Atlanta Falcons of S&P sectors. Home Depot (HD) , Nordstrom (JWN) , Lowe's (LOW) and Macy's on the downside. Watch Sears Holdings (SHLD) , another new low. Homebuilders continue to weaken. Old tech broadly lower, but fractionally so. Fertilizers for sale today. I still dont like the stocks -- with a six months time frame. Biotech unchanged though large-cap long favorite for 2017, Allergan (AGN) -- back up on the day ($3), continuing its amazing streak. Now up $40 from late December when I put name on Best Ideas List. Speculative biotech got beaten up again (Aratana Therapeutics (PETX) , Intrexon (XON) , ZIOPHARM Oncology (ZIOP) , Sage Therapeutics (SAGE) , Aerie Pharmaceuticals (AERI) , etc.). Big pharma broadly higher, but gains are small. Ag equipment a tad lower. Caterpillar (CAT) has dropped by $7 in the last week or two. That's my favorite large cap short for 2017 (opposite of AGN!). Consumer staples off on currency strength. Long fav, Campbell Soup (CPB) down a large fraction. I would be a buyer under $61/share. (T)FANG was mixed with Tesla (TSLA)  upside leader. I am looking to reestablish my ProShares Trust UltraPro Short QQQ ETF (SQQQ) long if I see any more weakness. Here are some value-added contributions on our site today: 1. Jim "EL Capitan" Cramer takes an

Baby Steps Real Money Pro($)

I have moved from small-sized to slightly more than small-sized in my financial shorts. I have added Bank of America  (BAC) $23.31, …

Some Late Day Observations Real Money Pro($)

My favorite large-cap short for 2017, Caterpillar (CAT) , is beginning to show signs of rolling over.   Metlife (MET) is at th…
Apple (AAPL) stole the show. Without AAPL, the market would have had a much different character. (Read: More negative). Today had something for everyone. For the bears, there was a

Sis Boom Blah Real Money Pro($)

I always am in wonderment how the business media highlights the positives (stocks/sectors that are rising TODAY) and de-emphasizes the negatives …
Prefer second-level thinking to first-level thinking -- by taking a skeptical and realistic view of possible regulatory changes, the slope of interest rates and other determining factors that influence industry profits. Among other things, second-level thinking weighs whether the share-price advance in the sector had discounted the optimistic consensus thinking and aggressive earnings assumptions. Speaking of consensus, always consider how strong and self confident the market's bias is and how realistic its assumptions might be. Glibness is always a red flag for me -- it is a "trigger" and often generates the start of my analysis. I took on small short positions in the banks (and medium-sized positions in GS, Metlife (MET) and Lincoln National (LNC) ) because I admitted in my writing that I was not as confident as the many we listen to in the media and Wall Street. The only certainty in managing money is the lack of certainty. We only have to look at the Trump election win and the market's post-victo

My Takeaways and Observations Real Money Pro($)

The U.S. dollar is stronger today. Oil dropped by a half buck to $52.63. Gold added $6. Ag commodities: wheat down $0.06, corn down $0.04, soybeans down $0.27 (!!) and oats down $0.08. (Be careful fertilizer freaks! Me, no like.) Lumber down $3. Bonds were quiet with small gains in yield and a two basis point increase in the 2s/10s spread. Municipals were up small in price -- as were closed-end muni-bond funds. High yield was junky, but Blackstone/GSO Strategic Credit Fund (BGB) was unchanged. Banks got hit -- I explained further why I have a trading short in sector in my Diary today (and above). When the stocks went up every day, commentary was omnipresent in the business media. Now, crickets. Insurance schmeissed, though my long, Hartford Financial (HIG)  , was barely lower. Brokerages got hit, Goldman Sachs (GS) was a feature to the downside. Retail showed signs of life -- a good thing. Several up 1% to 2% in a down tape (Nordstrom (JWN) , Walmart (WMT) , Kohl's (KSS) and J.C. Penney (JCP) ). Sears looks Chapter 11. (See above.) Biotech down 1.5% led by long fav Allergan (AGN) and Celgene (CELG) . Speculative biotech was particularly weak (FibroGen (FGEN) , Aerie Pharmaceuticals (AERI) , Intrexon (XON) ). Autos were lower but divergence between Ford (F) and General Motors (GM) is terrific for my pairs trade which is "kicking into gear." Ag equipment schmeissed, including fav large-cap short for 2017, Caterpillar (CAT) . Fertilizers wounded (see my comments about ag commodities, above). Consumer staples were mixed to lower. Campbell Soup (CPB) was higher most of the day, but faded in the afternoon. Coca-Cola (KO) still has no fizz despite some technical support mentioned last week on ReaLMoneyPro. Media was mixed. Disney (DIS) up, Comcast (CMCSA) down. Homebuilders appeared to have had a false breakout about a week ago and are lower again after recent weakness in last few days. (T)FANG hit on immigration ban (Silicon Valley is among the most diverse areas of the country) -- all five down, led by Amazon (AMZN) , which declined $5. In individual stocks, normal profit taking in DuPont (DD) (I have been whittling down and now I am small-sized -- what a winner its been over last 14 months!) Radian (RDN) resisting the lower market. Apple down small in front of this week's earnings report. Here are some value-added contributions on our site today: 1. Jim "El Capi

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.